Global Monoclonal Antibodies Market

Growing demand for Monoclonal Antibodies therapy is expected to increase market share in
the Global Monoclonal Antibodies market during the forecast period 2018-2023.
Market Overview:
Monoclonal antibodies are highly specific to cancer cells as they bind to the proteins on their
surface and stimulate an immune response. Monoclonal Antibodies (mAbs) are mono-specific
antibodies bodies comprising of identical immune cells that are clones of a single parent cells
and are directed to a specific cellular targets. These antibodies are highly customizable as it is
specific in nature and also play a vital role in eliminating the cancerous cell during the cancer
treatment. Thus monoclonal antibodies are proved to be more effective when compared to
chemotherapy or other cancer treatment.
Request Report Sample: https://www.marketdataforecast.com/market-reports/globalmonoclonal-antibodies-market-1184/request-sample
Factors affecting market growth:
•
Increasing R&D activities in genomics studies. (+)
•
Rising advancements of technologies in genetic platforms. (+)
•
Growing awareness about various mAb applications among global population and
physicians. (+)
•
Increasing demand for monoclonal antibodies. (+)
•
Rising prevalence of cancer and other chronic diseases. (+)
•
Huge investments for conducting R&D activities. (-)
•
High cost for monoclonal antibodies treatment. (-)
Get your customized report: https://www.marketdataforecast.com/market-reports/globalmonoclonal-antibodies-market-1184/customize-report
Market Segmentation
The Global Monoclonal Antibodies Market is geographically segmented into
•
North America
•
Europe
•
Asia Pacific
•
Latin America
•
Middle East and Africa
North America holds the largest market share for monoclonal antibodies market due to
presence of well-established healthcare facilities, the rise in demand for advanced healthcare
systems and growing awareness regarding cancer treatments in this region.
Asia-Pacific is rapidly growing in monoclonal antibodies market due to healthcare expenditures,
increase in number of cancer patients, and improving healthcare facilities which expected to
record a high growth rate during the forecast period.
Browse full Table of Contents: https://www.marketdataforecast.com/press-releases/globalmonoclonal-antibodies-market-1189/
Key players:
Leading companies in the Global Monoclonal Antibodies Market are Seattle Genetics (U.S.),
Bristol-Myers Squibb (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Teva Pharmaceutical
Industries Ltd. (Israel) and Shanghai Junshi Bioscience Co.,Ltd. (China), GlaxoSmithKline plc
(U.K.), Novartis AG (Switzerland), Pfizer Inc. (U.S.), (U.S.), Eli Lilly and Company (U.S.), and
Thermo Fisher Scientific Inc.
Contact Info:
Name: Mr. Abhishek Shukla
Email: [email protected]
Organization: MarketDataForecast™
Address: 2nd Floor, Above ICICI Bank,B-44, Rd Number 3, Journalist Colony, Film
Nagar, Hyderabad, Telangana 500033, India.
Phone: +1-888-702-9626

Monoclonal Antibodies Market By Source (Murine, Chimeric, Humanized, Human) By Indication (Cancer, Autoimmune Diseases, Infectious Diseases, Cardiovascular Diseases, CNS Disorders, Others)

Download Report